Statistics for Skinbiotherapeutics PLC (id:4162 SBTX)

Valuation metrics

Market cap

37.12M

Enterprise value

27.00M

Trailing P/E (ttm)

-930.23

Forward P/E

-0.23

PEG ratio

-0.23

Price/Sales (ttm)

229.64

Price/Book (mrq)

855.26

Enterprise Value/Revenue

167.03

Enterprise Value/EBITDA

-9.00

Overview

Shares outstanding

228.44M

Float

143.41M

Shares short

% Held by insiders

0.19%

% Held by institutions

0.16%

Average volume (10 days)

1.05M

Average volume (90 days)

Price summary

52-Week low

7.00

52-Week high

19.70

52-Week change

-20.31%

Beta

1.75

50-Day moving average

13.20

200-Day moving average

10.99

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

June 30th, 2023

Most recent quarter (mrq)

December 31th, 2023

Profitability

Profit margin

64.51%

Operating margin

-1,300.68%

Operational effectiveness

Return on assets

-61.18%

Return on equity

-118.64%

Income statement

Revenue (ttm)

0.00

Revenue per share (ttm)

0.00

Quarterly revenue growth (yoy)

Gross profit (ttm)

85.19K

EBITDA

-2,999,083.00

Net income to common (ttm)

-2,884,957.00

Diluted EPS (ttm)

-0.02

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

2.84M

Total cash per share (mrq)

0.02

Total debt (mrq)

97.05K

Total Debt/Equity (mrq)

2.66

Current ratio (mrq)

657.10%

Book value per share (mrq)

0.02

Cash flow

Cash flow statement

-3,016,675.00

Levered free cash flow (LFCF)

-2,253,091.00